Literature DB >> 28801864

Isolation and characterization of iron chelators from turmeric (Curcuma longa): selective metal binding by curcuminoids.

Donald J Messner1, Christine Surrago2, Celia Fiordalisi2, Wing Yin Chung2, Kris V Kowdley3.   

Abstract

Iron overload disorders may be treated by chelation therapy. This study describes a novel method for isolating iron chelators from complex mixtures including plant extracts. We demonstrate the one-step isolation of curcuminoids from turmeric, the medicinal food spice derived from Curcuma longa. The method uses iron-nitrilotriacetic acid (NTA)-agarose, to which curcumin binds rapidly, specifically, and reversibly. Curcumin, demethoxycurcumin, and bisdemethoxycurcumin each bound iron-NTA-agarose with comparable affinities and a stoichiometry near 1. Analyses of binding efficiencies and purity demonstrated that curcuminoids comprise the primary iron binding compounds recovered from a crude turmeric extract. Competition of curcuminoid binding to the iron resin was used to characterize the metal binding site on curcumin and to detect iron binding by added chelators. Curcumin-Iron-NTA-agarose binding was inhibited by other metals with relative potency: (>90% inhibition) Cu2+ ~ Al3+ > Zn2+ ≥ Ca2+ ~ Mg2+ ~ Mn2+ (<20% inhibition). Binding was also inhibited by pharmaceutical iron chelators (desferoxamine or EDTA) or by higher concentrations of weak iron chelators (citrate or silibinin). Investigation of the physiological effects of iron binding by curcumin revealed that curcumin uptake by cultured cells was reduced >80% by addition of iron to the media; uptake was completely restored by desferoxamine. Ranking of metals by relative potencies for blocking curcumin uptake agreed with their relative potencies in blocking curcumin binding to iron-NTA-agarose. We conclude that curcumin can selectively bind toxic metals including iron in a physiological setting, and propose inhibition of curcumin binding to iron-NTA-agarose for iron chelator screening.

Entities:  

Keywords:  Curcuma longa; Curcumin; Iron; Metal chelation; Turmeric

Mesh:

Substances:

Year:  2017        PMID: 28801864      PMCID: PMC5955385          DOI: 10.1007/s10534-017-0038-6

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  33 in total

Review 1.  Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Ganesan Padmavathi; Javadi Monisha; Nand Kishor Roy; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2016-10-21       Impact factor: 8.739

2.  Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy.

Authors:  M Grootveld; J D Bell; B Halliwell; O I Aruoma; A Bomford; P J Sadler
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

3.  Silybin, a new iron-chelating agent.

Authors:  M Borsari; C Gabbi; F Ghelfi; R Grandi; M Saladini; S Severi; F Borella
Journal:  J Inorg Biochem       Date:  2001-06       Impact factor: 4.155

4.  Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.

Authors:  C Ireson; S Orr; D J Jones; R Verschoyle; C K Lim; J L Luo; L Howells; S Plummer; R Jukes; M Williams; W P Steward; A Gescher
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

Review 5.  Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.

Authors:  Julie S Jurenka
Journal:  Altern Med Rev       Date:  2009-06

6.  Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator.

Authors:  Yan Jiao; John Wilkinson; Xiumin Di; Wei Wang; Heather Hatcher; Nancy D Kock; Ralph D'Agostino; Mary Ann Knovich; Frank M Torti; Suzy V Torti
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

Review 7.  Curcumin: from ancient medicine to current clinical trials.

Authors:  H Hatcher; R Planalp; J Cho; F M Torti; S V Torti
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

Review 8.  Regulation of proliferation of normal and neoplastic rat liver cells by calcium and cyclic AMP.

Authors:  S H Swierenga; J F Whitfield; A L Boynton; J P MacManus; R H Rixon; M Sikorska; B K Tsang; P R Walker
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

9.  Curcumin may impair iron status when fed to mice for six months.

Authors:  Dawn Chin; Patricia Huebbe; Jan Frank; Gerald Rimbach; Kathrin Pallauf
Journal:  Redox Biol       Date:  2014-02-28       Impact factor: 11.799

Review 10.  A Review on Iron Chelators in Treatment of Iron Overload Syndromes.

Authors:  Naser Mobarra; Mehrnoosh Shanaki; Hassan Ehteram; Hajar Nasiri; Mehdi Sahmani; Mohsen Saeidi; Mehdi Goudarzi; Hoda Pourkarim; Mehdi Azad
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-10-01
View more
  3 in total

1.  Iron biodistribution profile changes in the rat spleen after administration of high-fat diet or iron supplementation and the role of curcumin.

Authors:  Aziz Awaad; Hekmat Osman Abdel Aziz
Journal:  J Mol Histol       Date:  2021-05-28       Impact factor: 2.611

Review 2.  Boosting the Photoaged Skin: The Potential Role of Dietary Components.

Authors:  Ruixuan Geng; Seong-Gook Kang; Kunlun Huang; Tao Tong
Journal:  Nutrients       Date:  2021-05-16       Impact factor: 5.717

Review 3.  Role of Iron Chelation and Protease Inhibition of Natural Products on COVID-19 Infection.

Authors:  Giuseppe Carota; Simone Ronsisvalle; Federica Panarello; Daniele Tibullo; Anna Nicolosi; Giovanni Li Volti
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.